PLK3 Gene <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">PLK3 Gene</th> </tr> <tr> <td class="label">Gene Symbol</td> <td>PLK3</td> </tr> <tr> <td class="label">Gene Name</td> <td>Polo-Like Kinase 3</td> </tr> <tr> <td class="label">Aliases</td> <td>CNK3, PRPK</td> </tr> <tr> <td class="label">Chromosomal Location</td> <td>6p12.3</td> </tr> <tr> <td class="label">NCBI Gene ID</td> <td>9133</td> </tr> <tr> <td class="label">UniProt ID</td> <td>Q9H8S3</td> </tr> <tr> <td class="label">Ensembl ID</td> <td>ENSG00000176287</td> </tr> <tr> <td class="label">Gene Type</td> <td>Protein Coding</td> </tr> <tr> <td class="label">Disease</td> <td>Evidence Level</td> </tr> <tr> <td class="label">Cancer</td> <td>Confirmed</td> </tr> <tr> <td class="label">Neurodegeneration</td> <td>Moderate</td> </tr> <tr> <td class="label">Stroke</td> <td>Moderate</td> </tr> <tr> <td class="label">Protein</td> <td>Interaction Type</td> </tr> <tr> <td class="label">p53</td> <td>Phosphorylation</td> </tr> <tr> <td class="label">Chk2</td> <td>Kinase</td> </tr> <tr> <td class="label">Centrosomal proteins</td> <td>Localization</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
Overview ...
PLK3 Gene <table class="infobox infobox-gene"> <tr> <th class="infobox-header" colspan="2">PLK3 Gene</th> </tr> <tr> <td class="label">Gene Symbol</td> <td>PLK3</td> </tr> <tr> <td class="label">Gene Name</td> <td>Polo-Like Kinase 3</td> </tr> <tr> <td class="label">Aliases</td> <td>CNK3, PRPK</td> </tr> <tr> <td class="label">Chromosomal Location</td> <td>6p12.3</td> </tr> <tr> <td class="label">NCBI Gene ID</td> <td>9133</td> </tr> <tr> <td class="label">UniProt ID</td> <td>Q9H8S3</td> </tr> <tr> <td class="label">Ensembl ID</td> <td>ENSG00000176287</td> </tr> <tr> <td class="label">Gene Type</td> <td>Protein Coding</td> </tr> <tr> <td class="label">Disease</td> <td>Evidence Level</td> </tr> <tr> <td class="label">Cancer</td> <td>Confirmed</td> </tr> <tr> <td class="label">Neurodegeneration</td> <td>Moderate</td> </tr> <tr> <td class="label">Stroke</td> <td>Moderate</td> </tr> <tr> <td class="label">Protein</td> <td>Interaction Type</td> </tr> <tr> <td class="label">p53</td> <td>Phosphorylation</td> </tr> <tr> <td class="label">Chk2</td> <td>Kinase</td> </tr> <tr> <td class="label">Centrosomal proteins</td> <td>Localization</td> </tr> <tr> <td class="label">KG Connections</td> <td><a href="/atlas" style="color:#4fc3f7">1 edges</a></td> </tr> </table>
Overview PLK3 (Polo-Like Kinase 3) is a serine/threonine kinase involved in cell cycle regulation, DNA damage response, and cellular stress responses. While primarily studied in cancer biology, PLK3 has emerging roles in neuronal survival and neurodegenerative disease pathogenesis[@xie2002].
Protein Structure PLK3 contains key regulatory domains:
Kinase domain : Catalytic serine/threonine kinase at N-terminus
Polo box domain : C-terminal substrate recognition domain
N-terminal regulatory region : Autoinhibition and protein interactions
The polo box domain is involved in substrate recognition and cellular localization[@liu2007].
Biological Functions PLK3 performs multiple critical cellular functions:
Cell Cycle Regulation
G2/M transition : Controls entry into mitosis
DNA damage checkpoint : Activates checkpoint signaling
Mitotic progression : Ensures proper chromosome segregation
Cytokinesis : Regulates cell division completion
Stress Response PLK3 responds to various cellular stresses:
DNA damage response activation
Oxidative stress signaling
Hypoxia response
Oncogenic stress
Centrosome Maturation Essential for mitotic spindle formation:
Centrosome maturation and separation
Spindle assembly checkpoint
Proper mitotic spindle organization
Expression Pattern PLK3 is expressed in various tissues:
Proliferating cells : High in dividing cells
Brain tissue : [Neurons](/entities/neurons) and glia
Other organs : Moderate expression throughout
In neurons, PLK3 participates in:
DNA damage response to genotoxic stress
Cell cycle regulatory pathways
Stress-activated signaling cascades
Role in Neurodegeneration
DNA Damage Response Neurons are particularly vulnerable to DNA damage:
Accumulation : DNA lesions accumulate with age and disease
Response pathways : PLK3 activates repair mechanisms
Failure consequences : Leads to neuronal [apoptosis](/entities/apoptosis)
Cell Cycle Re-Entry Aberrant cell cycle activity in neurons is pathological:
Post-mitotic neurons inappropriately re-enter cell cycle
Leads to genomic instability
Triggers apoptotic pathways
Contributes to neurodegeneration
Parkinson's Disease PLK3 may be relevant to PD through:
DNA damage in dopaminergic neurons
Cell cycle regulatory dysfunction
Mitochondrial stress responses
Disease Associations
Interacting Partners PLK3 interacts with key regulatory proteins:
Therapeutic Implications PLK3 represents a potential therapeutic target:
DNA damage response modulation : Protecting neurons from genotoxic stress
Cell cycle inhibition : Preventing aberrant neuronal cell cycle re-entry
Neuroprotective strategies : Combined approaches for neuroprotection
See Also
[Cell Cycle](/mechanisms/cell-cycle) - Cell division
[DNA Damage](/mechanisms/dna-damage) - Genomic stress
[Apoptosis](/mechanisms/apoptosis) - Cell death
[Parkinson's Disease](/diseases/parkinsons-disease) - PD overview
External Links
[NCBI Gene - PLK3](https://www.ncbi.nlm.nih.gov/gene/9133)
[UniProt - Q9H8S3](https://www.uniprot.org/uniprot/Q9H8S3)
References
[Xie W et al, Polo-like kinase 3 functions in DNA damage response (2002)](https://pubmed.ncbi.nlm.nih.gov/12432084/)
[Liu X et al, Polo-like kinases in cell cycle regulation (2007)](https://pubmed.ncbi.nlm.nih.gov/18066060/)
Show full description